Jared Leto's rep denies sexual misconduct allegations made against the actor-singer
One anonymous woman, a model and music producer, said in 2006, when she was 16, Leto approached her at a cafe in Los Angeles and grabbed her arm. At the time, he was seated with actress Ashley Olsen, 19, whom he was rumoured to be dating.
'I looked down and it was Jared Leto,' the woman said. 'We had a quick conversation, and he got my number.'
She added that a few days later, Leto called her home in the middle of the night and invited her to a party he was hosting at his house. She said the calls kept coming in over the next three weeks 'always at 1, 2, 3am", even though she had declined the invite. She said the conversations "turned sexual".
Former model Laura La Rue, 33, also recounted a similar encounter with Leto in 2008, when she was 16 as well. She shared with Airmail that she met Leto at an animal rights benefit held at a private residence in Beverly Hills, where he was 'watching her so intensely'. At that time, Leto was 36. He is now 53.
Rue added that on a separate visit, Leto walked out of a room completely naked.
In response, Leto's representative denied La Rue's claims, stating: 'Their communications contain nothing sexual or inappropriate and Ms La Rue later applied to work as Mr Leto's personal assistant, further underscoring the absence of anything inappropriate in any of their interactions.'
La Rue, however, has denied applying for said position.
In response to the AirMail report, Leto's representative has stated that 'all of the allegations are expressly denied". The actor himself has not publicly responded.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNA
8 hours ago
- CNA
Google settles YouTube children's privacy lawsuit
Google will pay $30 million to settle a lawsuit claiming it violated the privacy of children using YouTube by collecting their personal information without parental consent, and using it to send targeted ads. A preliminary settlement of the proposed class action was filed on Monday night in San Jose, California, federal court, and requires approval by U.S. Magistrate Judge Susan van Keulen. Google denied wrongdoing in agreeing to settle. The Alphabet unit agreed in 2019 to pay $170 million in fines and change some practices to settle similar charges by the U.S. Federal Trade Commission and New York Attorney General Letitia James. Some critics viewed that accord as too lenient. Google did not immediately respond to requests for comment on Tuesday. Lawyers for the plaintiffs did not immediately respond to similar requests. The parents or guardians of 34 children accused Google of violating dozens of state laws by letting content providers bait children with cartoons, nursery rhymes and other content to help it collect personal information, even after the 2019 settlement. Van Keulen dismissed claims against the content providers -including Hasbro, Mattel, Cartoon Network and DreamWorks Animation - in January, citing a lack of evidence tying them to Google's alleged data collection. Mediation began the next month, leading to the settlement. The proposed class covers U.S. children under 13 who watched YouTube between July 1, 2013 and April 1, 2020. Lawyers for the plaintiffs said there could be 35 million to 45 million class members. They said if 1 per cent to 2 per cent submit claims, a rate comparable to similar earlier cases, claimants could receive $30 to $60 each, before deducting legal fees and costs. The lawyers plan to seek up to $9 million from the settlement for legal fees. Alphabet posted net income of $62.7 billion on revenue of $186.7 billion in the first half of 2025.
Independent Singapore
12 hours ago
- Independent Singapore
87% of videogame developers use AI agents following record layoffs, Google study finds
Photo: Freepik/DC Studio (for illustration purposes only) A Google Cloud survey found that 87% of video game developers now rely on artificial intelligence (AI) agents to streamline work, with most using them to handle repetitive tasks so they can focus on creative work, as the industry shifts its focus to optimising costs after record layoffs. The survey, carried out with The Harris Poll in late June and early July, asked 615 developers in the United States, South Korea, Norway, Finland and Sweden. Reuters reported that gaming publishers have turned to AI to manage rising development costs and longer production timelines, driven by high player expectations and fierce competition in the market. About 44% of respondents said they use AI agents to optimise content and quickly process text, code, voice, audio and video. Still, the use of AI in video games remains contentious, with many in the industry voicing concerns about intellectual property, job losses, and lower pay. Last year, video game performers in Hollywood went on strike over pay concerns and AI use, while more than 10,000 jobs were lost as studios shut down. In early July, Bloomberg also reported that Microsoft's gaming unit will cut about 10% of staff, affecting around 200 workers, a move the company later confirmed without giving further details. Even with the wave of job cuts, the industry is expected to pick up pace this year and next, helped by the launch of premium titles and new consoles. The survey showed that 94% of developers expect AI to lower development costs in the long run, although about a quarter said it is still difficult to measure its return on investment, and high integration costs remain a hurdle. At the same time, 63% raised concerns over data ownership, as questions around licensing and the rights to AI-generated content remain unclear. /TISG Read also: Microsoft to cut about 6,000 staff globally as AI investments push spending () => { const trigger = if ('IntersectionObserver' in window && trigger) { const observer = new IntersectionObserver((entries, observer) => { => { if ( { lazyLoader(); // You should define lazyLoader() elsewhere or inline here // Run once } }); }, { rootMargin: '800px', threshold: 0.1 }); } else { // Fallback setTimeout(lazyLoader, 3000); } });
CNA
a day ago
- CNA
'Ketamine queen' to plead guilty to supplying dose that killed Friends actor Matthew Perry
The accused Los Angeles drug dealer known as the "ketamine queen" has agreed to plead guilty to charges that she supplied the dose of the prescription anesthetic that killed Friends star Matthew Perry, prosecutors said on Monday (Aug 18). Jasveen Sangha, 42, who authorities said ran an illegal narcotics "stash house" in the North Hollywood district of Los Angeles and was due to stand trial in September, will plead guilty to five charges under a deal with federal prosecutors, according to the US Justice Department. Four other co-defendants in the case – two physicians, Perry's personal assistant and another man who admitted acting as an intermediary in selling ketamine to the actor – have already pleaded guilty to various charges, though none has yet been sentenced. All five were charged in the case one year ago. Prosecutors said Sangha agreed to plead guilty to one count of maintaining a drug-involved premises, three counts of illegal distribution of ketamine and one count of distribution of ketamine resulting in death. Sangha, a dual US-British citizen, is expected to formally enter her plea in the coming weeks, the Justice Department said in a statement. The charge of maintaining a drug den carries a statutory maximum sentence of 20 years in prison. Sangha faces up to 15 years in prison for ketamine distribution that killed Perry, and 10 years for each of the three other distribution counts. Medical examiners concluded that Perry died from acute effects of ketamine that combined with other factors to cause the actor to lose consciousness and drown in his hot tub on Oct 28, 2023. He was 54 years old. FAME AND ADDICTION Perry had publicly acknowledged decades of substance abuse, including periods that overlapped with the height of his fame playing the sardonic but charming Chandler Bing on the 1990s hit NBC television comedy Friends. Perry's death came a year after publication of his memoir, Friends, Lovers, and The Big Terrible Thing, which chronicled bouts with addiction to prescription painkillers and alcohol that he wrote had come close to ending his life more than once. His autopsy cited interviews with associates who said Perry had been sober for 19 months prior to his death with no known substance abuse relapses. Ketamine, a short-acting anaesthetic with hallucinogenic properties, is sometimes prescribed to treat depression and anxiety but also is abused by recreational users. According to Sangha's plea agreement as outlined by the Justice Department, Sangha had supplied 51 vials of ketamine from her stash house to a go-between dealer, Erik Fleming, 55, who in turn sold the doses to Perry through his live-in personal assistant, Kenneth Iwamasa, 60. It was Iwamasa, prosecutors said, who later injected Perry with at least three shots of ketamine from the vials Sangha supplied, resulting in the actor's death, and who subsequently found him lifeless in the hot tub. In her plea agreement, prosecutors said, Sangha also admitted selling ketamine to an individual in August 2019 who died hours later from a drug overdose. Known to her customers on the street as the "ketamine queen", according to prosecutors, Sangha had used her North Hollywood home to store, package and distribute various narcotics, including ketamine and methamphetamine, dating back to at least June 2019. After learning of news reports of Perry's death, prosecutors said, Sangha tried to scrub her Signal app of all her communications with Fleming and urged him to do likewise, instructing him to "Delete all our messages." Her plea deal came three weeks after a doctor who ran an urgent care clinic, Salvador Plasencia, 43, pleaded guilty to four counts of ketamine distribution and admitted to having injected Perry with the drug at the actor's home and in the back seat of a parked car. Another physician, Mark Chavez, 55, of San Diego, accused of illegally supplying ketamine to Plasencia, pleaded guilty to one count of conspiracy to distribute the drug.
